TrialJournal of diabetes investigation2022

A randomized trial to investigate the efficacy and safety of once-daily liraglutide 1.8 mg in Japanese adults with type 2 diabetes exhibiting an inadequate response to liraglutide 0.9 mg.

Yutaka Seino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.